JP Morgan Chase
ZYME icon

JP Morgan Chase’s Zymeworks ZYME Stock Holding History

JP Morgan Chase’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-50,000
Closed -$2.36M – 6415
2020
Q4 		$2.36M Buy
+50,000
New +$2.32M ﹤0.01% 3365

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

JP Morgan Chase's ZYME Position: Q2 2026 in Review

JP Morgan Chase reduced its Zymeworks (ZYME) stake by 6.7% in Q2 2026, selling an estimated $195K and leaving 106,398 shares worth $2.56M. The position accounts for ﹤0.01% of the portfolio, ranked #4016.

JP Morgan Chase first reported a position in ZYME in Q1 2019 and has held it in 27 quarters since. The position peaked at $5.54M in Q2 2025. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • JP Morgan Chase held 106,398 shares of Zymeworks worth $2.56M as of Q2 2026.
  • JP Morgan Chase sold 7,674 Zymeworks shares in Q2 2026, an estimated $195K.
  • Zymeworks made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4016 holding.
  • JP Morgan Chase first reported a position in Zymeworks in Q1 2019 and has held it in 27 quarters since.
  • JP Morgan Chase's Zymeworks position peaked at $5.54M in Q2 2025.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.